Setting

Global Influenza Treatment Market 2020-2030 by Product Type, Influenza Type, Administration Route, Distribution Channel, and Region: Trend Forecast and Growth Opportunity

Published: 26 Aug 2020 | Report Code: 10247645 | Pages: 156

Global influenza treatment market will reach $1,371.0 billion by 2030, growing by 3.8% annually over 2020-2030 driven by rising incidences of influenza, growing awareness and need for new drugs and treatment across the globe. Highlighted with 83 tables and 77 figures, this 156-page report “Global Influenza Treatment Market 2020-2030 by Product Type, Influenza Type, Administration Route, Distribution Channel, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global influenza treatment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global influenza treatment market in every aspect of the classification from perspectives of Product Type, Influenza Type, Administration Route, Distribution Channel, and Region. Based on Product Type, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Oseltamivir Phosphate • Baloxavir Marboxil • Peramivir • Zanamivir • Other Drugs Based on Influenza Type, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Influenza A • Influenza B • Influenza C Based on Administration Route, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Oral Administration • Other Administration Routes Based on Distribution Channel, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Retail Pharmacy • Hospital Pharmacy • Clinics • Online Stores Geographically, the following regions together with the listed national/local markets are fully investigated: • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka) • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania) • North America (U.S., Canada, and Mexico) • South America (Brazil, Chile, Argentina, Rest of South America) • RoW (Saudi Arabia, UAE, South Africa) For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Product Type, Administration Route, and Distribution Channel over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Specifically, potential risks associated with investing in global influenza treatment market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions. Key Players (this may not be a complete list and extra companies can be added upon request): AstraZeneca Plc BioCryst Pharmaceuticals Inc. Biondvax Daiichi Sankyo Company F. Hoffmann-La Roche Ltd. (Genentech USA, Inc.) GlaxoSmithKline Plc Mylan N.V Natco Pharma Limited Novartis AG Sanofi Seqirus Teva Pharmaceutical Industries Limited (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents

1 Introduction	8
1.1 Industry Definition and Research Scope	8
1.1.1 Industry Definition	8
1.1.2 Research Scope	9
1.2 Research Methodology	12
1.2.1 Overview of Market Research Methodology	12
1.2.2 Market Assumption	13
1.2.3 Secondary Data	13
1.2.4 Primary Data	13
1.2.5 Data Filtration and Model Design	15
1.2.6 Market Size/Share Estimation	16
1.2.7 Research Limitations	17
1.3 Executive Summary	18
2 Market Overview and Dynamics	20
2.1 Market Size and Forecast	20
2.1.1 Impact of COVID-19 on the Market	21
2.2 Major Growth Drivers	23
2.3 Market Restraints and Challenges	27
2.4 Emerging Opportunities and Market Trends	30
2.5 Porter’s Fiver Forces Analysis	34
3 Segmentation of Global Market by Product Type	38
3.1 Market Overview by Product Type	38
3.2 Oseltamivir Phosphate	40
3.3 Baloxavir Marboxil	41
3.4 Peramivir	42
3.5 Zanamivir	43
3.6 Other Drugs	44
4 Segmentation of Global Market by Influenza Type	45
4.1 Market Overview by Influenza Type	45
4.2 Influenza A	47
4.3 Influenza B	48
4.4 Influenza C	49
5 Segmentation of Global Market by Administration Route	50
5.1 Market Overview by Administration Route	50
5.2 Oral Administration	52
5.3 Other Administration Routes	53
6 Segmentation of Global Market by Distribution Channel	54
6.1 Market Overview by Distribution Channel	54
6.2 Retail Pharmacy	56
6.3 Hospital Pharmacy	57
6.4 Clinics	58
6.5 Online Stores	59
7 Segmentation of Global Market by Region	60
7.1 Geographic Market Overview 2019-2030	60
7.2 North America Market 2019-2030 by Country	66
7.2.1 Overview of North America Market	66
7.2.2 U.S.	70
7.2.3 Canada	74
7.2.4 Mexico	76
7.3 European Market 2019-2030 by Country	78
7.3.1 Overview of European Market	78
7.3.2 Germany	82
7.3.3 UK	84
7.3.4 France	86
7.3.5 Spain	88
7.3.6 Italy	90
7.3.7 Russia	92
7.3.8 Rest of European Market	94
7.4 Asia-Pacific Market 2019-2030 by Country	96
7.4.1 Overview of Asia-Pacific Market	96
7.4.2 Japan	100
7.4.3 China	103
7.4.4 Australia	105
7.4.5 India	107
7.4.6 South Korea	109
7.4.7 Rest of APAC Region	111
7.5 South America Market 2019-2030 by Country	113
7.5.1 Argentina	116
7.5.2 Brazil	118
7.5.3 Chile	120
7.5.4 Rest of South America Market	122
7.6 MEA Market 2019-2030 by Country	123
7.6.1 UAE	126
7.6.2 Saudi Arabia	128
7.6.3 South Africa	130
7.6.4 Other National Markets	132
8 Competitive Landscape	133
8.1 Overview of Key Vendors	133
8.2 New Product Launch, Partnership, Investment, and M&A	136
8.3 Company Profiles	137
AstraZeneca Plc	137
BioCryst Pharmaceuticals Inc.	139
Biondvax	140
Daiichi Sankyo Company	141
F. Hoffmann-La Roche Ltd. (Genentech USA, Inc.)	142
GlaxoSmithKline Plc	143
Mylan N.V	144
Natco Pharma Limited	145
Novartis AG	146
Sanofi	147
Seqirus	148
Teva Pharmaceutical Industries Limited	149
9 Investing in Global Market: Risk Assessment and Management	150
9.1 Risk Evaluation of Global Market	150
9.2 Critical Success Factors (CSFs)	153
Related Reports and Products	156
List Of Tables

Table 1.  Snapshot of Global Influenza Treatment Market, 2019-2030	19
Table 2.  Main Product Trends and Market Opportunities in Global Influenza Treatment Market	30
Table 3. Global Influenza Treatment Market by Product Type, 2019-2030, $ mn	38
Table 4. Global Influenza Treatment Market by Influenza Type, 2019-2030, $ mn	45
Table 5. Global Influenza Treatment Market by Administration Route, 2019-2030, $ mn	50
Table 6. Global Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn	54
Table 7. Global Influenza Treatment Market by Region, 2019-2030, $ mn	61
Table 8. Total Health Expenditure per capita in PPP International U.S. Dollars by Country	63
Table 9.  Leading National Influenza Treatment Market, 2019 and 2030, $ mn	65
Table 10. North America Influenza Treatment Market by Country, 2019-2030, $ mn	68
Table 11. U.S. Influenza Treatment Market by Product Type, 2019-2030, $ mn	72
Table 12. U.S. Influenza Treatment Market by Administration Route, 2019-2030, $ mn	72
Table 13. U.S. Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn	72
Table 14. Canada Influenza Treatment Market by Product Type, 2019-2030, $ mn	75
Table 15. Canada Influenza Treatment Market by Administration Route, 2019-2030, $ mn	75
Table 16. Canada Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn	75
Table 17. Mexico Influenza Treatment Market by Product Type, 2019-2030, $ mn	77
Table 18. Mexico Influenza Treatment Market by Administration Route, 2019-2030, $ mn	77
Table 19. Mexico Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn	77
Table 20. Europe Influenza Treatment Market by Country, 2019-2030, $ mn	81
Table 21. Germany Influenza Treatment Market by Product Type, 2019-2030, $ mn	83
Table 22. Germany Influenza Treatment Market by Administration Route, 2019-2030, $ mn	83
Table 23. Germany Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn	83
Table 24. UK Influenza Treatment Market by Product Type, 2019-2030, $ mn	85
Table 25. UK Influenza Treatment Market by Administration Route, 2019-2030, $ mn	85
Table 26. UK Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn	85
Table 27. France Influenza Treatment Market by Product Type, 2019-2030, $ mn	87
Table 28. France Influenza Treatment Market by Administration Route, 2019-2030, $ mn	87
Table 29. France Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn	87
Table 30. Spain Influenza Treatment Market by Product Type, 2019-2030, $ mn	89
Table 31. Spain Influenza Treatment Market by Administration Route, 2019-2030, $ mn	89
Table 32. Spain Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn	89
Table 33. Italy Influenza Treatment Market by Product Type, 2019-2030, $ mn	91
Table 34. Italy Influenza Treatment Market by Administration Route, 2019-2030, $ mn	91
Table 35. Italy Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn	91
Table 36. Russia Influenza Treatment Market by Product Type, 2019-2030, $ mn	93
Table 37. Russia Influenza Treatment Market by Administration Route, 2019-2030, $ mn	93
Table 38. Russia Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn	93
Table 39. Influenza Treatment Market in Rest of Europe by Country, 2019-2030, $ mn	95
Table 40. APAC Influenza Treatment Market by Country, 2019-2030, $ mn	98
Table 41. Japan Influenza Treatment Market by Product Type, 2019-2030, $ mn	102
Table 42. Japan Influenza Treatment Market by Administration Route, 2019-2030, $ mn	102
Table 43. Japan Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn	102
Table 44. China Influenza Treatment Market by Product Type, 2019-2030, $ mn	104
Table 45. China Influenza Treatment Market by Administration Route, 2019-2030, $ mn	104
Table 46. China Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn	104
Table 47. Australia Influenza Treatment Market by Product Type, 2019-2030, $ mn	106
Table 48. Australia Influenza Treatment Market by Administration Route, 2019-2030, $ mn	106
Table 49. Australia Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn	106
Table 50. India Influenza Treatment Market by Product Type, 2019-2030, $ mn	108
Table 51. India Influenza Treatment Market by Administration Route, 2019-2030, $ mn	108
Table 52. India Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn	108
Table 53. South Korea Influenza Treatment Market by Product Type, 2019-2030, $ mn	110
Table 54. South Korea Influenza Treatment Market by Administration Route, 2019-2030, $ mn	110
Table 55. South Korea Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn	110
Table 56. Influenza Treatment Market in Rest of APAC by Country, 2019-2030, $ mn	112
Table 57. South America Influenza Treatment Market by Country, 2019-2030, $ mn	115
Table 58. Argentina Influenza Treatment Market by Product Type, 2019-2030, $ mn	117
Table 59. Argentina Influenza Treatment Market by Administration Route, 2019-2030, $ mn	117
Table 60. Argentina Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn	117
Table 61. Brazil Influenza Treatment Market by Product Type, 2019-2030, $ mn	119
Table 62. Brazil Influenza Treatment Market by Administration Route, 2019-2030, $ mn	119
Table 63. Brazil Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn	119
Table 64. Chile Influenza Treatment Market by Product Type, 2019-2030, $ mn	121
Table 65. Chile Influenza Treatment Market by Administration Route, 2019-2030, $ mn	121
Table 66. Chile Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn	121
Table 67. MEA Influenza Treatment Market by Country, 2019-2030, $ mn	125
Table 68. UAE Influenza Treatment Market by Product Type, 2019-2030, $ mn	127
Table 69. UAE Influenza Treatment Market by Administration Route, 2019-2030, $ mn	127
Table 70. UAE Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn	127
Table 71. Saudi Arabia Influenza Treatment Market by Product Type, 2019-2030, $ mn	129
Table 72. Saudi Arabia Influenza Treatment Market by Administration Route, 2019-2030, $ mn	129
Table 73. Saudi Arabia Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn	129
Table 74. South Africa Influenza Treatment Market by Product Type, 2019-2030, $ mn	131
Table 75. South Africa Influenza Treatment Market by Administration Route, 2019-2030, $ mn	131
Table 76. South Africa Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn	131
Table 77. AstraZeneca Plc: Company Snapshot	137
Table 78. AstraZeneca Plc: Business Segmentation	137
Table 79. AstraZeneca Plc: Product Portfolio	138
Table 80. AstraZeneca Plc: Revenue, 2016-2018, $ mn	138
Table 81. AstraZeneca Plc: Recent Developments	138
Table 82.  Risk Evaluation for Investing in Global Market, 2019-2030	151
Table 83. Critical Success Factors and Key Takeaways	154
List Of Figures

Figure 1. Research Method Flow Chart	12
Figure 2. Breakdown of Primary Research	14
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation	16
Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030	18
Figure 5. Global Influenza Treatment Market, 2019-2030, $ mn	20
Figure 6. Impact of COVID-19 on Business	21
Figure 7. Primary Drivers and Impact Factors of Global Influenza Treatment Market	23
Figure 8. GDP per capita in the World, 1960-2018, $ thousand	26
Figure 9. Forecast of Middle-class Population by Region, 2015-2030, million	26
Figure 10. Primary Restraints and Impact Factors of Global Influenza Treatment Market	27
Figure 11. Investment Opportunity Analysis	31
Figure 12. Porter’s Fiver Forces Analysis of Global Influenza Treatment Market	34
Figure 13. Breakdown of Global Influenza Treatment Market by Product Type, 2019-2030, % of Revenue	38
Figure 14. Global Addressable Market Cap in 2020-2030 by Product Type, Value ($ mn) and Share (%)	39
Figure 15. Global Influenza Treatment Market: Oseltamivir Phosphate, 2019-2030, $ mn	40
Figure 16. Global Influenza Treatment Market: Baloxavir Marboxil, 2019-2030, $ mn	41
Figure 17. Global Influenza Treatment Market: Peramivir, 2019-2030, $ mn	42
Figure 18. Global Influenza Treatment Market: Zanamivir, 2019-2030, $ mn	43
Figure 19. Global Influenza Treatment Market: Other Drugs, 2019-2030, $ mn	44
Figure 20. Breakdown of Global Influenza Treatment Market by Influenza Type, 2019-2030, % of Sales Revenue	45
Figure 21. Global Addressable Market Cap in 2020-2030 by Influenza Type, Value ($ mn) and Share (%)	46
Figure 22. Global Influenza Treatment Market: Influenza A, 2019-2030, $ mn	47
Figure 23. Global Influenza Treatment Market: Influenza B, 2019-2030, $ mn	48
Figure 24. Global Influenza Treatment Market: Influenza C, 2019-2030, $ mn	49
Figure 25. Breakdown of Global Influenza Treatment Market by Administration Route, 2019-2030, % of Sales Revenue	50
Figure 26. Global Addressable Market Cap in 2020-2030 by Administration Route, Value ($ mn) and Share (%)	51
Figure 27. Global Influenza Treatment Market: Oral Administration, 2019-2030, $ mn	52
Figure 28. Global Influenza Treatment Market: Other Administration Routes, 2019-2030, $ mn	53
Figure 29. Breakdown of Global Influenza Treatment Market by Distribution Channel, 2019-2030, % of Revenue	54
Figure 30. Global Addressable Market Cap in 2020-2030 by Distribution Channel, Value ($ mn) and Share (%)	55
Figure 31. Global Influenza Treatment Market: Retail Pharmacy, 2019-2030, $ mn	56
Figure 32. Global Influenza Treatment Market: Hospital Pharmacy, 2019-2030, $ mn	57
Figure 33. Global Influenza Treatment Market: Clinics, 2019-2030, $ mn	58
Figure 34. Global Influenza Treatment Market: Online Stores, 2019-2030, $ mn	59
Figure 35.  Global Market Snapshot by Region	60
Figure 36.  Geographic Spread of Worldwide Influenza Treatment Market, 2019-2030, % of Sales Revenue	61
Figure 37. Global Addressable Market Cap in 2020-2030 by Region, Value ($ mn) and Share (%)	62
Figure 38. Health Spending as a Share of GDP by Country, 2015 and 2030	64
Figure 39.  North American Influenza Treatment Market, 2019-2030, $ mn	67
Figure 40. Breakdown of North America Influenza Treatment Market by Country, 2019 and 2030, % of Revenue	68
Figure 41. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)	69
Figure 42. U.S. Influenza Treatment Market, 2019-2030, $ mn	71
Figure 43. Canada Influenza Treatment Market, 2019-2030, $ mn	74
Figure 44.  Influenza Treatment Market in Mexico, 2015-2030, $ mn	76
Figure 45.  European Influenza Treatment Market, 2019-2030, $ mn	79
Figure 46. Breakdown of European Influenza Treatment Market by Country, 2019 and 2030, % of Revenue	80
Figure 47. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)	81
Figure 48.  Influenza Treatment Market in Germany, 2019-2030, $ mn	82
Figure 49.  Influenza Treatment Market in UK, 2019-2030, $ mn	84
Figure 50.  Influenza Treatment Market in France, 2019-2030, $ mn	86
Figure 51.  Influenza Treatment Market in Spain, 2019-2030, $ mn	88
Figure 52.  Influenza Treatment Market in Italy, 2019-2030, $ mn	90
Figure 53.  Influenza Treatment Market in Russia, 2019-2030, $ mn	92
Figure 54.  Influenza Treatment Market in Rest of Europe, 2019-2030, $ mn	94
Figure 55. Asia-Pacific Influenza Treatment Market, 2019-2030, $ mn	97
Figure 56. Breakdown of APAC Influenza Treatment Market by Country, 2019 and 2030, % of Revenue	97
Figure 57. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)	99
Figure 58.  Influenza Treatment Market in Japan, 2019-2030, $ mn	101
Figure 59.  Influenza Treatment Market in China, 2019-2030, $ mn	103
Figure 60.  Influenza Treatment Market in Australia, 2019-2030, $ mn	105
Figure 61.  Influenza Treatment Market in India, 2019-2030, $ mn	107
Figure 62.  Influenza Treatment Market in South Korea, 2019-2030, $ mn	109
Figure 63.  Influenza Treatment Market in Rest of APAC, 2019-2030, $ mn	111
Figure 64. South America Influenza Treatment Market, 2019-2030, $ mn	114
Figure 65. Breakdown of South America Influenza Treatment Market by Country, 2019 and 2030, % of Revenue	114
Figure 66. Contribution to South America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)	115
Figure 67.  Influenza Treatment Market in Argentina, 2019-2030, $ mn	116
Figure 68.  Influenza Treatment Market in Brazil, 2019-2030, $ mn	118
Figure 69.  Influenza Treatment Market in Chile, 2019-2030, $ mn	120
Figure 70.  Influenza Treatment Market in Rest of South America, 2019-2030, $ mn	122
Figure 71. Influenza Treatment Market in Middle East and Africa (MEA), 2019-2030, $ mn	124
Figure 72. Breakdown of MEA Influenza Treatment Market by Country, 2019 and 2030, % of Revenue	124
Figure 73. Contribution to MEA 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)	125
Figure 74.  Influenza Treatment Market in UAE, 2019-2030, $ mn	126
Figure 75.  Influenza Treatment Market in Saudi Arabia, 2019-2030, $ mn	128
Figure 76.  Influenza Treatment Market in South Africa, 2019-2030, $ mn	130
Figure 77. Growth Stage of Global Influenza Treatment Industry over the Forecast Period	133

Key Players (this may not be a complete list and extra companies can be added upon request): 
AstraZeneca Plc	
BioCryst Pharmaceuticals Inc.	
Biondvax	
Daiichi Sankyo Company	
F. Hoffmann-La Roche Ltd. (Genentech USA, Inc.)	
GlaxoSmithKline Plc	
Mylan N.V	
Natco Pharma Limited	
Novartis AG	
Sanofi	
Seqirus	
Teva Pharmaceutical Industries Limited